Stryker (NYSE:SYK) today agreed to pay $52 million to acquire TSO3 (TSX:TOS) and its Sterizone VP4 sterilizer. The C43¢-per-share offer works out to about C$68.4 million ($51.7 million), representing an 18% premium on the 30-day volume-weighted average share price, Quebec City-based TSO3 said. “TSO3‘s board of directors and management believe that this transaction provides the best […]
TSO3
TSO3 touts publication of Sterizone VP4 duodenoscope sterilization study
TSO3 (TSE:TOS) yesterday touted the publication of results from a study exploring clinical in-use and simulated use testing of terminal sterilization of duodenoscopes with its Sterizone VP4 sterilizer. Results from the study were published in the American Journal of Infection Control, the Quebec City-based company said. Results from the study indicated that the Sterizone hydrogen peroxide-ozone […]
TSO3 drops Getinge, lands $20m debt round for Sterizone VP4
TSO3 (TSE:TOS) said today it is dropping a distribution agreement with Getinge and that it inked a $20 million debt financing deal with a fund under advisement by Courage Capital Management to support commercialization of its Sterizone VP4 sterilizer. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone […]
TSO3 wins expanded FDA nod for Sterizone VP4 sterilizer
TSO3 (TSE:TOS) said late yesterday it won expanded FDA 510(k) clearance for its Sterizone VP4 sterilizer, clearing a new feature of the system that the company claims can improve installation of the device and reduce oxygen supply requirements. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone for […]
TSO3 responds to FDA info request for Sterizone VP4 duoedenoscope indications
TSO3 (TSE:TOS) said today it responded to a request for additional information from the FDA on its Sterizone VP4 sterilizer as it seeks an indication for the terminal sterilization of duodenoscopes. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone for the terminal sterilization of heat and […]
TSO3 rebounds after short-seller’s report triggers plunge
Share prices for TSO3 (TSE:TOS) rebounded somewhat today after taking a beating yesterday on a short-seller’s report questioning the company’s stability. The short seller, Spruce Point Mgmt., accused the Canadian company of not disclosing the installed customer base for its Sterizone VP4 sterilizer as promised this year because, “if it did, investors might see just […]
TSO3 files FDA app seeking duodenoscope indication for Sterizone VP4 sterilizer
TSO3 said today it filed a 510(k) application with the FDA as it seeks to clear its Sterizone VP4 sterilizer for the terminal sterilization of duodenoscopes used in endoscopic retrograde cholangio-pancreatography procedures. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone for the terminal sterilization of […]
7 medtech stories we missed this week: June 23, 2017
From Guardant suing Foundation Medicine to Interson receiving 510(k) clearance for ultrasound probes, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Guardant levels false advertising suit against Foundation Medicine Guardant Health announced in a June 22 press release that it has filed a lawsuit against Foundation Medicine […]
FDA expands indication for TSO3’s sterilization device
Canadian medical sterilization device company TSO3 said yesterday it won expanded FDA clearance for its Sterizone VP4 sterilizer device, including clearance for sterilizing double and multiple-channel endoscopes. The expanded approval was based on testing which showed the company’s Sterizone VP4 sterilizer effective when used with both double and multi-channel flexible endoscopes, including ureteroscopes or video […]
Fujifilm Medical Systems names new COO, CMO | Personnel Moves
Fujifilm Holdings (TSE:4901) said its Fujifilm Medical Systems U.S.A. subsidiary lured an Accuray (NSDQ:ARAY) executive and a physician from the University of Southern California to its executive roster effective Sept. 28. The Stamford, Conn.-based company said Johann Fernando, formerly Accuray’s vice president & general manager, was named to be its operations chief. Dr. Diku Mandavia, who has […]
TSO3 launches US subsidiary
Canadian medical sterilization device company TSO3 said yesterday it is opening shop in the U.S. with a wholly owned subsidiary based in Myrtle Beach, S.C. The American subsidiary, named the TSO3 Corporation, is slated to open its doors in August, the Québec City-based company said. “Alone and together with our sales and service partner Getinge Infection […]